DESCRIPTION OF CLINICAL, PARACLINICAL FEATURES AND PREGNANCY RATE OF PATIENTS WHO RESPOND POORLY TO OVARIAN STIMULATION

Hoàng Quốc Huy1, , Lê Thị Hương Lan2, Nguyễn Thu Thủy1, Nguyễn Thị Anh1, Nguyễn Thị Kim Tiến1, Nguyễn Thị Hồng1
1 Thai Nguyen University of Medicine and Pharmacy
2 Thai Nguyen Central General Hospital

Main Article Content

Abstract

Objectives: To describe the clinical and paraclinical characteristics and comment on the number of oocytes and the pregnancy rate of patients who have a poor ovarian response to ovarian stimulation. Subjects and methods: A cross-sectional descriptive study of 60 cases of poor response to ovarian stimulation who were examined and treated at the National Center for Assisted Reproductive Technology - National Hospital of Obstetrics and Gynecology from January 2021 to September 2021. Results and discussion: The poor response to ovarian stimulation was mainly in elderly patients with a mean age of 36,78 ± 4,95 years and a relatively long duration of infertility of 5,00 ± 2,87 years. The patients who responded poorly to ovarian stimulation exhibited a low mean AMH index of 1,04 ± 0,82 ng/ml and a low number of secondary follicles of 5,57 ± 1,48 follicles. The average number of oocytes retrieved was 5,10 ± 2,27. In which the number of MII oocytes accounted for the most with 4,23 ± 1,89. The proportion of patients who tested positive for hCG was 13,56%. The clinical pregnancy rate is 10,17%. The ongoing pregnancy rate was 8,47%. Stillbirth rate: the control group had 1 case of stillbirth, accounting for 1,67%. The biochemical pregnancy rate with 2 cases of biochemical pregnancy accounted for 3,39%.

Article Details

References

1. Jeve YB, Bhandari HM. Effective treatment protocol for poor ovarian response: A systematic review and meta-analysis. J Hum Reprod Sci. 2016;9(2):70-81. doi:10.4103/0974-1208.183515
2. Ferraretti AP, La Marca A, Fauser BCJM, Tarlatzis B, Nargund G, Gianaroli L. ESHRE consensus on the definition of “poor response” to ovarian stimulation for in vitro fertilization: the Bologna criteria. Human Reproduction. 2011; 26(7):1616-1624. doi:10.1093/humrep/der092
3. Nguyễn Thị Ngọc Phượng. Nội tiết sinh sản nữ: cơ chế tác động và điều hòa. In: Nội Tiết Sinh Sản.; 2011:27-34.
4. Kim CH, Ahn JW, Moon JW, Kim SH, Chae HD, Kang BM. Ovarian Features after 2 Weeks, 3 Weeks and 4 Weeks Transdermal Testosterone Gel Treatment and Their Associated Effect on IVF Outcomes in Poor Responders. Dev Reprod. 2014; 18(3):145-152. doi:10.12717/DR.2014.18.3.145
5. Doan HT, Quan LH, Nguyen TT. The effectiveness of transdermal testosterone gel 1% (androgel) for poor responders undergoing in vitro fertilization. Gynecological Endocrinology. 2017; 33 (12):977-979. doi:10.1080/ 09513590.2017.1332586
6. Vương Thị Ngọc Lan. Kích thích buồng trứng và các tác động lên kết quả kỹ thuật hỗ trợ sinh sản. In: Thụ Tinh Trong Ống Nghiệm. NXB Giáo Dục Việt Nam; 2011:343-372.
7. Nguyễn Việt Hà. Hiệu quả của testosterone dạng gel trên các bệnh nhân thụ tinh trong ống nghiệm giảm dự trữ buồng trứng. Trường Đại học Y Hà Nội; 2017.
8. Balasch J, Fábregues F, Peñarrubia J, et al. Pretreatment with transdermal testosterone may improve ovarian response to gonadotrophins in poor-responder IVF patients with normal basal concentrations of FSH. Human Reproduction. 2006;21(7):1884-1893. doi:10.1093/humrep/del052